1. Home
  2. BKH vs AMRX Comparison

BKH vs AMRX Comparison

Compare BKH & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Black Hills Corporation

BKH

Black Hills Corporation

HOLD

Current Price

$74.17

Market Cap

5.6B

Sector

Utilities

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$17.20

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKH
AMRX
Founded
1941
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
6.2B
IPO Year
2001
2018

Fundamental Metrics

Financial Performance
Metric
BKH
AMRX
Price
$74.17
$17.20
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$77.80
$15.60
AVG Volume (30 Days)
670.9K
1.6M
Earning Date
05-06-2026
05-01-2026
Dividend Yield
3.78%
N/A
EPS Growth
1.79
157.89
EPS
2.23
0.37
Revenue
$2,310,000,000.00
N/A
Revenue This Year
$4.98
$4.48
Revenue Next Year
$3.92
$7.13
P/E Ratio
$33.27
$46.08
Revenue Growth
8.57
N/A
52 Week Low
$58.10
$9.49
52 Week High
$78.69
$19.26

Technical Indicators

Market Signals
Indicator
BKH
AMRX
Relative Strength Index (RSI) 55.58 41.26
Support Level $70.30 $16.61
Resistance Level $75.86 $18.58
Average True Range (ATR) 1.28 0.45
MACD 0.12 -0.09
Stochastic Oscillator 82.58 7.94

Price Performance

Historical Comparison
BKH
AMRX

About BKH Black Hills Corporation

Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: